{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T16:01:49Z","timestamp":1773504109068,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":206,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.idcr.2019.e00611","type":"journal-article","created":{"date-parts":[[2019,7,27]],"date-time":"2019-07-27T11:10:47Z","timestamp":1564225847000},"page":"e00611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Necrotizing fasciitis associated with sorafenib treatment"],"prefix":"10.1016","volume":"18","author":[{"given":"Ho Won","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok-Joong","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wun-Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2019.e00611_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020461","article-title":"Effects and side effects of using sorafenib and sunitinib in the treatment of metastatic renal cell carcinoma","volume":"18","author":"Randrup Hansen","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.idcr.2019.e00611_bib0010","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1365-2133.2009.09290.x","article-title":"Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib","volume":"161","author":"Lee","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.idcr.2019.e00611_bib0015","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40264-014-0139-x","article-title":"Effect of tyrosine kinase inhibitors on wound healing and tissue repair: implications for surgery in cancer patients","volume":"37","author":"Shah","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.idcr.2019.e00611_bib0020","first-page":"18","volume":"1452","author":"Biondi","year":"2013"},{"key":"10.1016\/j.idcr.2019.e00611_bib0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4103\/0253-7613.125195","article-title":"Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma","volume":"46","author":"\u015eendur","year":"2014","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.idcr.2019.e00611_bib0030","doi-asserted-by":"crossref","first-page":"e259","DOI":"10.1016\/S1470-2045(13)70222-5","article-title":"Bevacizumab is linked to cases of necrotising fasciitis","volume":"14","author":"Wong","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.idcr.2019.e00611_bib0035","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.clgc.2013.11.017","article-title":"Extensive necrotizing fasciitis associated with sunitinib therapy","volume":"12","author":"Piszczek","year":"2014","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.idcr.2019.e00611_bib0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1749-7922-6-46","article-title":"Necrotizing fasciitis: literature review of contemporary strategies for diagnosing and management with three case reports: torso, abdominal wall, upper and lower limbs","volume":"6","author":"Roje","year":"2011","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.idcr.2019.e00611_bib0045","first-page":"45","article-title":"A practitioner\u2019s guide to necrotizing fasciitis","volume":"40","author":"Harrington","year":"2015","journal-title":"Nurse Pr"},{"key":"10.1016\/j.idcr.2019.e00611_bib0050","doi-asserted-by":"crossref","first-page":"378","DOI":"10.11622\/smedj.2014090","article-title":"Liver cirrhosis as a real risk factor for necrotising fasciitis: a three-year population-based follow-up study","volume":"55","author":"Hung","year":"2014","journal-title":"Singapore Med J"},{"key":"10.1016\/j.idcr.2019.e00611_bib0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/0253-7613.125192","article-title":"A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions","volume":"46","author":"Belhekar","year":"2014","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.idcr.2019.e00611_bib0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.idcr.2019.e00611_bib0065","first-page":"55","article-title":"Fournier\u2019s gangrene as a possible side effect of bevacizumab therapy for resected colorectal cancer","volume":"9","author":"Gamboa","year":"2010","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.idcr.2019.e00611_bib0070","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1471-2334-14-198","article-title":"Necrotizing fasciitis caused by Haemophilus influenzae type b in a patient with rectal cancer treated with combined bevacizumab and chemotherapy: a case report","volume":"14","author":"Ugai","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.idcr.2019.e00611_bib0075","article-title":"Necrotizing fasciitis associated with Staphylococcus lugdunensis","volume":"2012","author":"Hung","year":"2012","journal-title":"Case Rep Infect Dis"},{"key":"10.1016\/j.idcr.2019.e00611_bib0080","doi-asserted-by":"crossref","DOI":"10.1136\/hrt.2004.040659","article-title":"Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles","volume":"91","author":"Anguera","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.idcr.2019.e00611_bib0085","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/jcm.29.3.419-421.1991","article-title":"Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection","volume":"29","author":"Herchline","year":"1991","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idcr.2019.e00611_bib0090","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3201\/eid1108.041177","article-title":"Staphylococcus lugdunensis pacemaker-related infection","volume":"11","author":"Seifert","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idcr.2019.e00611_bib0095","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jamcollsurg.2008.10.032","article-title":"Necrotizing fasciitis: current concepts and review of the literature","volume":"208","author":"Sarani","year":"2009","journal-title":"J Am Coll Surg"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250919301222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250919301222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:02:13Z","timestamp":1761998533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250919301222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":19,"alternative-id":["S2214250919301222"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2019.e00611","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Necrotizing fasciitis associated with sorafenib treatment","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2019.e00611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e00611"}}